Science & Enterprise subscription

Follow us on Twitter

  • An industry-academic consortium received a U.S. government contract to develop coded synthetic polymer chemicals li… https://t.co/AqWMpFYG5Q
    about 15 hours ago
  • New post on Science and Enterprise: Synthetic DNA Studied for Mass Data Storage https://t.co/XeKsILkGR0 #Science #Business
    about 15 hours ago
  • Engineers developed a more sustainable type of concrete adding a form of bacteria to grow and reproduce the materia… https://t.co/7naaOf9CYF
    about 19 hours ago
  • New post on Science and Enterprise: Living, Reproducing Concrete Created with Bacteria https://t.co/1RWPEfpvmz #Science #Business
    about 19 hours ago
  • Smart money? The US company receiving the most venture capital money through 2019 is e-cigarette maker Juul Labs, a… https://t.co/YHMyj4Aavo
    about 2 days ago

Please share Science & Enterprise

Venture Deals, Dollars Fall in Q4 2019; Biotech Stays Hot

Global venture capital investing

Venture capital deal-making in the U.S. declined in the fourth quarter of 2019, but biotechnology start-ups remained the most sought-after investment targets of any sector. . . . → Read More: Venture Deals, Dollars Fall in Q4 2019; Biotech Stays Hot

UPMC to Invest $1 Billion in Medical Enterprises

UPMC lab

UPMC, the medical center affiliated with University of Pittsburgh, plans to invest $1 billion in life science advances, with spin-off companies as part of its strategy. . . . → Read More: UPMC to Invest $1 Billion in Medical Enterprises

New Biotech Aims to Bring Down Drug Prices

Pills on money

A biotechnology company launched yesterday that plans to discover and develop therapies faster and at lower cost than many of today’s new drugs. . . . → Read More: New Biotech Aims to Bring Down Drug Prices

Vaccine Developer Gains $11M in Early Funds

Baby with microcephaly

A company designing vaccines delivered with a microneedle patch to prevent infectious diseases is raising $11 million in its first venture funding round. . . . → Read More: Vaccine Developer Gains $11M in Early Funds

Infographic – Biotech Index Zooms to New High

NBI chart

Since October, the Nasdaq Biotechnology Index rose steadily to a new high for the year, as shown in this weekend’s infographic. . . . → Read More: Infographic – Biotech Index Zooms to New High

Synthetic Bio Cancer Immunotherapy Company Acquired

Natural killer cell

A biotechnology company creating synthetic proteins that invoke the immune system to fight cancer is being acquired by drug maker Astellas Pharma. . . . → Read More: Synthetic Bio Cancer Immunotherapy Company Acquired

Touch Sensor Developer Gains $12M in Early Funds

HaptX glove

A company making gloves that transmit a sense of touch in games and commercial robotics is raising $12 million in its first venture funding round. . . . → Read More: Touch Sensor Developer Gains $12M in Early Funds

Engineered Viruses Licensed for Cancer Therapies

Vaccinia virus

A biotechnology company developing cancer immunotherapies with synthetic viruses is licensing its technology to Takeda Pharmaceuticals. . . . → Read More: Engineered Viruses Licensed for Cancer Therapies

Synthetic Bio Company Acquired in $2.35B Deal

E. coli bacteria

A company developing protein-like therapies for cancer from synthetic bacteria is being acquired by drug maker Sanofi in a deal valued at $2.35 billion. . . . → Read More: Synthetic Bio Company Acquired in $2.35B Deal

Radiology A.I. Company Raises $4M in Seed Funds

Inspecting lung X-rays

A start-up company developing systems with artificial intelligence to aid the work of radiologists is raising $4 million in its seed funding round. . . . → Read More: Radiology A.I. Company Raises $4M in Seed Funds